Sykes M - Search Results

1

Xenotransplantation from pig to cynomolgus monkey: the potential for overcoming xenograft rejection through induction of chimerism.

Tanaka M, Latinne D, Gianello P, Sablinski T, Lorf T, Bailin M, Nickeleit V, Colvin R, Lebowitz E, Sykes M, et al. Tanaka M, et al. Among authors: sykes m. Transplant Proc. 1994 Jun;26(3):1326-7. Transplant Proc. 1994. PMID: 8029926 No abstract available.

2

Dissociating graft-vs-host disease from the graft-vs-leukemia effect of allogeneic T cells: the potential role of IL-2.

Sykes M. Sykes M. Bone Marrow Transplant. 1992;10 Suppl 1:1-4. Bone Marrow Transplant. 1992. PMID: 1521080 Review. No abstract available.

3

Alloengraftment in IL-2-treated mice.

Sykes M, Pearson DA. Sykes M, et al. Bone Marrow Transplant. 1992 Aug;10(2):157-63. Bone Marrow Transplant. 1992. PMID: 1525605

4

The mechanism of IL-2-mediated protection against GVHD in mice. II. Protection occurs independently of NK/LAK cells.

Sykes M, Abraham VS. Sykes M, et al. Transplantation. 1992 May;53(5):1063-70. doi: 10.1097/00007890-199205000-00018. Transplantation. 1992. PMID: 1533968

5

Effect of natural antibody on xenogeneic bone marrow engraftment.

Sykes M, Sachs DH, Aksentijevich I. Sykes M, et al. Transplant Proc. 1992 Apr;24(2):497-8. Transplant Proc. 1992. PMID: 1566403 No abstract available.

6

Humoral tolerance in xenogeneic BMT recipients conditioned by a nonmyeloablative regimen.

Aksentijevich I, Sachs DH, Sykes M. Aksentijevich I, et al. Among authors: sykes m. Transplantation. 1992 May;53(5):1108-14. doi: 10.1097/00007890-199205000-00025. Transplantation. 1992. PMID: 1585475

7

Tolerance and xenograft survival.

Sachs DH, Sykes M, Greenstein JL, Cosimi AB. Sachs DH, et al. Among authors: sykes m. Nat Med. 1995 Sep;1(9):969. doi: 10.1038/nm0995-969. Nat Med. 1995. PMID: 7585228 Review. No abstract available.

8

IL-2-induced GVHD protection is not inhibited by cyclosporine and is maximal when IL-2 is given over a 25 h period beginning on the day following bone marrow transplantation.

Sykes M, Pearson DA, Szot GL. Sykes M, et al. Bone Marrow Transplant. 1995 Mar;15(3):395-9. Bone Marrow Transplant. 1995. PMID: 7599564

9

Inhibition of graft-versus-host disease by interleukin-2 treatment is associated with altered cytokine production by expanded graft-versus-host-reactive CD4+ helper cells.

Wang MG, Szebeni J, Pearson DA, Szot GL, Sykes M. Wang MG, et al. Among authors: sykes m. Transplantation. 1995 Sep 15;60(5):481-90. doi: 10.1097/00007890-199509000-00014. Transplantation. 1995. PMID: 7676498

10

IL-2 inhibits early increases in serum gamma interferon levels associated with graft-versus-host-disease.

Szebeni J, Wang MG, Pearson DA, Szot GL, Sykes M. Szebeni J, et al. Among authors: sykes m. Transplantation. 1994 Dec 27;58(12):1385-93. Transplantation. 1994. PMID: 7809932

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

932 results

Search Page

Filters